Financial Highlights

Year ended or at December 31
(in millions, except per share data and notional value) 2013 2012 Change
Income Statement Data
Total revenues $2,936 $2,915 1%
Operating income 1,637 1,692 (3)
Income before income taxes 1,601 1,693 (5)
Net income attributable to CME Group 977 896 9
Earnings per common share attributable to CME Group:
Basic $2.94 $2.71 8%
Diluted 2.92 2.70 8
Balance Sheet Data
Current assets1 $3,050 $2,133 43%
Total assets1 32,923 32,278 2
Current liabilities1 1,956 1,032 90
Total liabilities1 11,762 10,773 9
CME Group shareholders’ equity 21,155 21,419 (1)
Other Data
Total contract volume (round turn trades) 3,161 2,890 9%
Total electronic volume (round turn trades) 2,727 2,464 11
Open interest at year end (contracts) 84 70 20
Notional value of trading volume (in trillions) $925 $806 15

1 Amounts exclude cash performance bonds and guaranty fund contributions.

2 2011 results include a $646 million non-cash benefit from a tax adjustment primarily due to a revaluation of our deferred tax liabilities.

All references to volume, open interest and notional value in the text of this document exclude our IRS, CDS, TRAKRS and CME Clearing Europe contracts.

See the 2013 Annual Report on Form 10-K for the company’s forward-looking statements.
Total Contract Volume: 09 - 2,585; 10 - 3,078; 11 - 3,387; 12 - 2,890; 13 - 3,161

Total Contract Volume

(in millions of round turn trades)
Total Revenues: 09 - 2,613; 10 - 3,004; 11 - 3,281; 12 - 2,915; 13 - 2,936

Total Revenues

(in millions of dollars)
Net Income: 09 - 826; 10 - 951; 11 - 1,812; 12 - 896; 13 - 977

Net Income
Attributable to CME Group2

(in millions of dollars)
Dividends Declared: 09 - 0.92; 10 - 0.92; 11 - 1.12; 12 - 3.70; 13 - 4.40

Dividends Declared

(in dollars per share)
Continue to: Company Achievements in 2013